Announced
Completed
Synopsis
Korelya Capital, a private equity firm, led a $28m funding round in Synapse Medicine, a medication intelligence company, with participation from XAnge, MACSF and BNP Paribas Development. "At Synapse Medicine, we have developed a medication reconciliation solution that simplifies the process and reduces prescribing discrepancies at each transition. This new funding round is an important milestone to further facilitate medication reconciliation and improve patient safety in the US," Clement Goehrs, Synapse Medicine Co-Founder and CEO.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.